| Active substance |
Peptide |
| Also known as |
Examorelin |
| Blood pressure |
May increase blood pressure |
| Chemical name |
(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4H-imidazol-4-yl)propanoyl]pyrrolidin-1-yl]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]-N-(2-amino-1-oxoethyl)pyrrolidine-1-carboxamide |
| Dosage (medical) |
Typically 1-2 mcg per kg of body weight |
| Dosage (sports) |
Typically 100-200 mcg, 2-3 times daily |
| Effects |
Increases growth hormone levels, enhances muscle growth, supports tissue repair, boosts metabolism |
| Formula |
C47H58N12O6 |
| Half-life |
Approximately 55 minutes |
| Hepatotoxicity |
None reported |
| Lab Test |
Growth Hormone levels, IGF-1 levels |
| Main action |
Growth hormone secretagogue |
| Side effects |
Increased cortisol levels, increased prolactin levels, possible joint pain, potential gynecomastia |
| Storage conditions |
Should be stored in a cool and dry place, away from light, usually refrigerated after reconstitution |
| Substance class |
Peptide |
| Trade name |
Hexarelin |
| Use in sports |
Used for muscle growth and performance enhancement |
| Water Retention |
Moderate |
| Active ingredient, mg |
5 |
| Release form |
Vial |
| 1 Ampoule, ml |
10 |
| Vials in the package, pcs |
1 |
| Manufacturer |
Peptide Sciences |
